{"nct_id":"NCT05421598","title":"Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma","status":"COMPLETED","status_verified_date":"2025-10","start_date":"2022-06-30","start_date_type":"ACTUAL","primary_completion_date":"2024-10-11","primary_completion_date_type":"ACTUAL","completion_date":"2025-03-20","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}